A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma
Clinical trial NCT00515697 · COMPLETED
Trial details
- NCT number
- NCT00515697
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2011-05-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.